U.S. Health Care REITs Stock News

NasdaqGS:PTC
NasdaqGS:PTCSoftware

3 Solid Balance Sheet Stocks With Quietly Powerful Cash Engines

Global inflation worries, rising bond yields and energy price swings are keeping markets on edge, which is why many investors are focusing on companies with strong balance sheets and efficient use of shareholder capital. The Solid Balance Sheet and Fundamentals screener highlights stocks with high return on equity, resilient past performance and prudent financial structures, qualities that can help support earnings quality when conditions are choppy. In this article, you will see 3 stocks...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

A Look At Zenas BioPharma (ZBIO) Valuation After Positive Obexelimab Phase 3 Data And FDA BLA Submission

Clinical data and regulatory milestones in focus Zenas BioPharma (ZBIO) stock is drawing attention after the company reported detailed Phase 3 INDIGO data for obexelimab in IgG4-Related Disease and advanced a Biologics License Application with the FDA. See our latest analysis for Zenas BioPharma. Despite the positive INDIGO data and recent Biologics License Application filing, Zenas BioPharma's share price has come under pressure, with the stock down 11.05% over 30 days and 49.36% year to...
NYSE:PAYC
NYSE:PAYCProfessional Services

A Look At Paycom Software (PAYC) Valuation After Recent Share Price Weakness

Paycom Software (PAYC) is back in focus after a recent share price move, with the stock closing at US$137.62. For investors, the discussion now centers on how this level compares with its fundamentals. See our latest analysis for Paycom Software. The 1-day share price gain of 0.39% comes after a weaker patch, with the share price down 9.7% year to date and the 1-year total shareholder return declining 46.25%, suggesting momentum has been fading despite a modest 4.33% 90-day share price...
NYSE:TDOC
NYSE:TDOCHealthcare Services

A Look At Teladoc Health (TDOC) Valuation After New Walmart Virtual Care Partnership

Teladoc Health (TDOC) is back in focus after expanding its virtual urgent care, dermatology, and nutrition services onto Walmart’s Better Care Services platform, giving the telehealth provider access to a broader retail customer base. See our latest analysis for Teladoc Health. At a share price of US$7.05, Teladoc Health has seen recent momentum cool, with a 7 day share price return down 10.87% and a 1 year total shareholder return down 4.73%. However, the 90 day share price return, up...
NYSE:WTM
NYSE:WTMInsurance

A Look At White Mountains Insurance Group’s Valuation After Its 2026 Annual Investor Presentation

White Mountains Insurance Group (WTM) is back in focus after its 2026 Annual Investor Presentation, which outlined 2025 results, growth in book value per share, record capital deployment, and several portfolio transactions. See our latest analysis for White Mountains Insurance Group. The 1-year total shareholder return of 15.61% contrasts with a softer 90-day share price return, which fell 7.12%. This suggests momentum has cooled even as investors who stayed invested longer have seen stronger...
NYSE:UMH
NYSE:UMHResidential REITs

Exploring 3 Undervalued Small Caps With Insider Buying Across Regions

Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 23% over the past year with earnings forecasted to grow by 17% annually. In this dynamic environment, identifying stocks that are undervalued and exhibit insider buying can be an effective strategy for investors seeking opportunities in small-cap companies across various regions.
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Discover RadNet And 2 Other Stocks Estimated To Be Trading Below Intrinsic Value

Over the last 7 days, the United States market has experienced a 2.5% decline, though it has seen a significant rise of 23% over the past year, with earnings projected to grow by 17% annually. In this context, identifying stocks that are estimated to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets in an evolving market landscape.
NYSE:MTZ
NYSE:MTZConstruction

Insider Favorites High Growth Companies June 2026

Over the last 7 days, the United States market has dropped 2.5%, yet it remains up by 23% over the past year, with earnings projected to grow by 17% annually in the coming years. In this fluctuating environment, identifying growth companies with high insider ownership can be particularly appealing as these firms often demonstrate strong potential and a vested interest from those who know them best.
NYSEAM:BRBS
NYSEAM:BRBSBanks

Undervalued Penny Stocks To Consider In June 2026

Over the last 7 days, the United States market has dropped 2.5%, but it remains up 23% over the past year with earnings forecasted to grow by 17% annually. For investors looking beyond well-known stocks, penny stocks—often representing smaller or newer companies—can present intriguing opportunities despite their somewhat outdated label. By focusing on those with strong financial health and potential for growth, investors might uncover valuable options in this niche area of the market.
NasdaqGS:CTBI
NasdaqGS:CTBIBanks

Dividend Stocks To Consider In June 2026

Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this dynamic environment, identifying dividend stocks that offer consistent payouts and potential for growth can be an effective strategy for investors seeking to balance income with capital appreciation.
NYSE:AM
NYSE:AMOil and Gas

Assessing Antero Midstream (AM) Valuation As Shares Trade Near US$21 And Long Term Returns Remain Strong

Event overview and recent stock context Antero Midstream (AM) continues to draw interest after recent trading, with the stock last closing at US$21.52. The company’s market value stands at about US$10.22b, supported by all reported revenue coming from the United States. See our latest analysis for Antero Midstream. Recent trading shows modest short term softness, with a 1 day share price return of 0.28% and a 90 day share price return down 4.74%. The year to date share price return of 19.96%...